As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides ...

Sample pooling, in which equal volumes from multiple specimens are combined and tested together, can reduce per-sample costs and increase testing throughput while preserving clinical performance.

The International Olympic Committee dropped genetic testing of female athletes in 1999 because of inaccuracies, high cost and psychological trauma. Now it's coming back.